These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5682096)

  • 21. Some observations on the alteration of the adhesiveness of human blood platelets after infusion with low molecular weight dextran.
    Lal HB; Caroli RK; Sengupta D; Basumalik SN; Khan MA; Malik RN; Warrik HP
    J Assoc Physicians India; 1968 Aug; 16(8):523-7. PubMed ID: 5700157
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of nitroglycerin in the early phase of acute myocardial infarct].
    Alexandrowicz A
    Kardiol Pol; 1979; 22(1):13-8. PubMed ID: 106181
    [No Abstract]   [Full Text] [Related]  

  • 23. [Low molecular weight dextran and fibrinolysis in men. II. Fibrinolysis activation by administering low molecular weight dextran in lymphedema].
    Tesi M; Brunetti S
    Riv Crit Clin Med; 1967 Aug; 67(3):216-32. PubMed ID: 5633533
    [No Abstract]   [Full Text] [Related]  

  • 24. MYOCARDIAL INFARCTION TREATED WITH LOW-MOLECULAR-WEIGHT DEXTRAN.
    LINDEN L
    Lancet; 1964 Oct; 2(7362):759. PubMed ID: 14193969
    [No Abstract]   [Full Text] [Related]  

  • 25. Intramyocardial perfusion with oxygenated blood or low-molecular dextran in experimental infarction in dogs.
    Haeger KH; Nordqvist SR
    Vasc Dis; 1965 Sep; 2(5):247-53. PubMed ID: 5866202
    [No Abstract]   [Full Text] [Related]  

  • 26. Vital rheologic variations in myocardial infarction.
    Langsjoen PH
    Biomed Sci Instrum; 1968; 4():36-41. PubMed ID: 5638856
    [No Abstract]   [Full Text] [Related]  

  • 27. [Anticoagulant therapy of acute myocardial infarct and its sequelae].
    Sorensen OH; Friis T; Wjorgensen AW; Jorgensen MB; Bnissen NI
    Ugeskr Laeger; 1968 Feb; 130(8):318-27. PubMed ID: 5676619
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effectiveness of early use of fibrinolysin in acute myocardial infarct under conditions of emergency aid].
    Krasheninnikova NG; Zil'berman DB; Taĭkh IaI; Chechik EA; Kamenetskaia IIa
    Vrach Delo; 1967 Feb; 2():39-42. PubMed ID: 4240530
    [No Abstract]   [Full Text] [Related]  

  • 29. [1st 4 weeks of rehabilitation in acute myocardial infarct].
    Lambić I; Nikolić Lj; Dekleva J; Krstić Lj; Radunović L
    Srp Arh Celok Lek; 1975 May; 103(5):373-80. PubMed ID: 1188479
    [No Abstract]   [Full Text] [Related]  

  • 30. [Rheopolyglucine treatment of patients with brain infarct in the acute period].
    Burova MT; Gorbacheva FE; Kvasov VT; Belkovskaia EE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(1):70-2. PubMed ID: 1119244
    [No Abstract]   [Full Text] [Related]  

  • 31. [Streptokinase in myocardial infarct].
    Lasierra Cirujeda L; Viladés Juan E; Fernández Clemente JJ; Dulin Verde JJ; Moreno Resina B; Munilla García A; Macho Fernandez A; Fernandez De La Cigoña F
    Rev Clin Esp; 1977 Feb; 144(4):251-7. PubMed ID: 847260
    [No Abstract]   [Full Text] [Related]  

  • 32. [LOW MOLECULAR DEXTRAN TREATMENT IN MYOCARDIAL INFARCT].
    LINDEN L
    Sven Lakartidn; 1964 Jul; 61():2300-5. PubMed ID: 14178283
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of native dextran of different average molecular weights on survival of acutely bled rats].
    Tokin I
    Vojnosanit Pregl; 1970 May; 27(5):217-20. PubMed ID: 5201599
    [No Abstract]   [Full Text] [Related]  

  • 34. [Results of treatment of the early stage of myocardial infarct with neuroleptanalgesia II].
    Sadowski Z; Kraska T; Pieniak M; Radecki A; Stopczyk M; Zochowski RJ
    Kardiol Pol; 1971; 14(2):213-8. PubMed ID: 5095317
    [No Abstract]   [Full Text] [Related]  

  • 35. [Mobilizing treatment of acute myocardial infarct and its clinical results].
    Thoenies H; Zenker K
    Dtsch Gesundheitsw; 1970 Mar; 25(10):438-43. PubMed ID: 5447199
    [No Abstract]   [Full Text] [Related]  

  • 36. [Anterior and posterior myocardial infarct: clinical comparative study on its outcome].
    Blanc JJ; Boschat J; Granatelli D; Morin JF; Penther P
    Arch Mal Coeur Vaiss; 1978 Aug; 71(8):865-9. PubMed ID: 101163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Thrombelastographic evaluation of hemocoagulation in acute myocardial infarct treated with sodium 3,4,5 trimethoxybenzoylaminocaproate].
    Zangara A; Dugoni D; Anselmi L
    Minerva Med; 1973 Mar; 64(16):803-11. PubMed ID: 4704724
    [No Abstract]   [Full Text] [Related]  

  • 38. [Evaluation of the therapeutic action of D-L carnitine in acute myocardial infarct (AMI) by changes in the serum myoglobin concentration curve. I. Myoglobin: earliest serum test of necrosis in the acute phase of myocardial infarction].
    D'Annunzio E; Mobilij A; D'Orazio G; Volpi G; Paloscia L; Rasetti G; Pontano O; Sclocco T
    Boll Soc Ital Cardiol; 1981; 26(11):1447-51. PubMed ID: 7349190
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hemodynamic properties of low molecular dextran in experimental clinical conditions].
    Rudowski W; Kostrzewska E; Scharf R; Konopka L; Gregor A; Rechowicz K; Czartoryska B; Klawe Z; Ostrowski J
    Pol Tyg Lek; 1967 Oct; 22(45):1719-22. PubMed ID: 6063015
    [No Abstract]   [Full Text] [Related]  

  • 40. [Thrombelastographic evaluation of blood coagulation in acute myocardial infarct treated with 3,4,5 trimethoxybenzoylaminocaproate sodium].
    Zangara A; Dugoni D; Anselmi L
    Minerva Med; 1973 Mar; 64(16):803-11. PubMed ID: 4723563
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.